Clinical Chemistry

Papers
(The H4-Index of Clinical Chemistry is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl142
Persistently Positive Urine Amphetamines Confirmation Testing93
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology88
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?82
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests70
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision70
Clinical Chemistry's Invited Reviewers 202463
A-154 Reduction in Turnaround Time Achieved by Simplifying Hematology Middleware Rules60
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?60
A-170 CBC Results, flags and scattergram using BC 6800Plus Hematology Analyzer, for a case of Burkitt*s lymphoma in leukemic phase59
A-213 Highlights on Daily Internal Quality Controls for Improved Analytical Performance in Clinical Laboratory58
A-268 Evaluation of NAAT Recovery of Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.4.4b from Novel Proficiency Samples56
A-032 Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer53
A-291 Rapidly Ruling Out Bacterial Infection: A Novel Host-Protein Assay for Patients with Suspected Respiratory Tract Infections in the Emergency Department52
A-172 Graphical contribution and CBC of BC-6800Plus hematology analyzer in a case of Myelodisplastic Syndrome related to Chemotherapy and Radiotherapy51
A-181 Stability of urine in the BD Vacutainer® Plus Conical Urinalysis Preservative Tubes for Chemical and Microscopic Urinalysis48
A-312 Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer45
B-043 Clinical performance evaluation of the ABD PAD® as confirmatory testing of blood group45
B-007 Activin A is a potential mediator of TGFß1-induced tubulointerstitial fibrosis37
B-088 Stability Assessment of Hormones and Tumor Markers: Can We Ensure High-Quality Patient Results Despite Operational Challenges?36
B-277 Validation of an Enzymatic Method for Quantification of Ethylene Glycol in Human Serum35
B-214 Migration of a Previously Validated Sequencing Workflow of 4,700 Genes Associated with Clinical Phenotypes to the MGI DNBSEQ-G400 Platform: High-Quality NGS Data with Elevated Concordance to Exp35
B-278 Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening33
A-072 The Impact of Short and Prolonged Fasting on Routine Lab Tests33
B-182 Evaluating Clinical Biochemical Diagnostic Approaches for Mitochondrial Diseases33
A-050 The Role of Gut Microbial Metabolite Trimethylamine N-Oxide in Adrenal Cholesterol Homeostasis33
B-117 Inverse Association Between Regulatory T and B Cells with HLA antibodies and Donor-specific Antibodies in Kidney Transplantation33
A-034 Prevention of Obesity and Metabolic Disorders Through a Gut Microbial Metabolite Derived from Polyphenol Supplementation in a High-Fat Diet33
B-314 Utility of he4 in differential diagnosis of pleural effusions32
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows32
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report32
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-1931
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test31
0.18411302566528